Research Grade Anti-SARS-CoV-2 RBD antibody (P2B-2F6) (RVV00302)

Catalog No.

RVV00302

Expression system

Mammalian Cells

Species reactivity

SARS-CoV-2 (2019-nCoV)

Host species

Human

Isotype

IgG1

Clonality

Monoclonal

Target

Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2

Concentration

7.3 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P0DTC2

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

Spike glycoprotein,S glycoprotein,E2,Peplomer protein,Spike protein S1,S,Receptor-Binding Domain,RBD,SARS

Clone ID

P2B-2F6

Rational optimization of a human neutralizing antibody of SARS-CoV-2 PMID: 34147856

Human neutralizing antibodies elicited by SARS-CoV-2 infection；PMID: 32454513

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry；PMID: 33431856

Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions；PMID: 33041212

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines；PMID: 33705729

Document Download

Research Grade Anti-SARS-CoV-2 RBD antibody (P2B-2F6).pdf